VACCINS ANTICANCER CIBLANT MUC16 ET LEURS UTILISATIONS

• 收藏
• 分享

专利权人:

Inovio Pharmaceuticals; Inc.

发明人:

申请号：

EP18887385.5

公开号：

EP3723812A1

申请日:

2018.12.13

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a modified consensus MUC16 antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a modified consensus MUC16 antigen are disclosed. Methods of treating a subject with a MUC16-expressing tumor and methods of preventing a MUC16-expressing tumor are disclosed. Modified consensus MUC16 antigen is disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/